INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 289 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,092,621 | +66280.4% | 15,953 | -33.0% | 0.00% | -42.9% |
| Q1 2024 | $1,646 | -12.6% | 23,800 | -9.5% | 0.01% | -12.5% |
| Q4 2023 | $1,883 | +29.6% | 26,300 | -5.7% | 0.01% | +33.3% |
| Q3 2023 | $1,453 | -15.0% | 27,900 | +3.3% | 0.01% | -14.3% |
| Q2 2023 | $1,709 | -49.1% | 27,000 | -56.5% | 0.01% | +40.0% |
| Q1 2023 | $3,360 | +194.0% | 62,100 | +187.5% | 0.01% | 0.0% |
| Q4 2022 | $1,143 | -99.9% | 21,600 | -30.1% | 0.01% | -28.6% |
| Q3 2022 | $1,437,000 | -18.5% | 30,900 | 0.0% | 0.01% | -12.5% |
| Q2 2022 | $1,763,000 | +123.4% | 30,900 | +139.5% | 0.01% | +166.7% |
| Q1 2022 | $789,000 | +81.8% | 12,900 | +55.4% | 0.00% | +50.0% |
| Q4 2021 | $434,000 | +57.8% | 8,300 | +12.2% | 0.00% | +100.0% |
| Q3 2021 | $275,000 | -8.9% | 7,400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $302,000 | +308.1% | 7,400 | +155.2% | 0.00% | – |
| Q3 2020 | $74,000 | -40.8% | 2,900 | -40.8% | 0.00% | -100.0% |
| Q2 2020 | $125,000 | +95.3% | 4,900 | +3.4% | 0.00% | – |
| Q3 2014 | $64,000 | – | 4,740 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 360,000 | $11,502,000 | 2.65% |
| Redmile Group, LLC | 610,171 | $19,495,000 | 1.60% |
| Pier Capital, LLC | 257,256 | $8,219,000 | 1.18% |
| WALL STREET ASSOCIATES | 358,857 | $11,465,000 | 1.08% |
| SENZAR ASSET MANAGEMENT, LLC | 161,300 | $5,154,000 | 0.88% |
| Rhenman & Partners Asset Management AB | 206,000 | $6,582,000 | 0.79% |
| EAM Investors, LLC | 152,389 | $4,869,000 | 0.57% |
| EDMOND DE ROTHSCHILD (SUISSE) S.A. | 50,000 | $1,598,000 | 0.51% |
| Visium Asset Management, LP | 1,051,479 | $33,595,000 | 0.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 128,000 | $4,090,000 | 0.40% |